New 2021 Forecasts Released

New Data
innovation hub

Novira Therapeutics (fka Molecmo Nanobiotechnologies) is Profiled in this Database

Updated At 20 Mar, 2012

Start Free 7 Day Trial Now
Partial description of this company
Antiviral pharmaceuticals that bind to caspids to treat HIV and HBV

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Novira Therapeutics (fka Molecmo Nanobiotechnologies) plus 4812 other startups.

Start Free 7 Day Trial Now

Learn More About Novira Therapeutics (fka Molecmo Nanobiotechnologies)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

More

Our Clients